| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 133 | 657 | 0 | 0 | 0 |
| Total Income - EUR | - | - | - | - | 0 | 249 | 15.079 | 3.451 | 25.419 | 3.422 |
| Total Expenses - EUR | - | - | - | - | 10.632 | 28.470 | 21.391 | 8.566 | 3.623 | 8.995 |
| Gross Profit/Loss - EUR | - | - | - | - | -10.632 | -28.221 | -6.311 | -5.114 | 21.796 | -5.573 |
| Net Profit/Loss - EUR | - | - | - | - | -10.632 | -28.222 | -6.318 | -5.114 | 18.309 | -5.573 |
| Employees | - | - | - | - | 5 | 5 | 3 | 1 | 0 | 1 |
Check the financial reports for the company - Biosuc Product S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 32.280 | 31.668 | 27.525 | 24.159 | 20.645 | 17.108 |
| Current Assets | - | - | - | - | 207 | 1.336 | 1.545 | 1.397 | 393 | 390 |
| Inventories | - | - | - | - | 173 | 294 | 452 | 361 | 179 | 178 |
| Receivables | - | - | - | - | 0 | 112 | 139 | 140 | 139 | 139 |
| Cash | - | - | - | - | 34 | 930 | 954 | 896 | 75 | 74 |
| Shareholders Funds | - | - | - | - | -10.590 | -38.611 | -44.073 | -49.324 | -30.865 | -36.266 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 43.077 | 29.739 | 35.637 | 40.708 | 21.276 | 26.730 |
| Income in Advance | - | - | - | - | 0 | 41.876 | 37.507 | 34.172 | 30.627 | 27.034 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1032 - 1032" | |||||||||
| CAEN Financial Year |
1032
|
|||||||||
Comments - Biosuc Product S.r.l.